Oral lipid nanomedicines: Current status and future perspectives in cancer treatment
Keywords: 
Oral delivery
Nanoparticles
Chemotherapy
Cancer
Solid lipid nanoparticle
Lymphatic system
Gastrointestinal barrier
Issue Date: 
2021
Publisher: 
Elsevier
ISSN: 
0169-409X
Note: 
This is an open access article under the CC BY-NC-ND license
Citation: 
El-Moukhtari, S.H. (Souhaila H.); Rodriguez-Nogales, C. (Carlos); Blanco-Prieto, M.J. (María José). "Oral lipid nanomedicines: Current status and future perspectives in cancer treatment". Advanced Drug Delivery Reviews. (173), 2021, 238 - 251
Abstract
Oral anticancer drugs have earned a seat at the table, as the need for homecare treatment in oncology has increased. Interest in this field is growing as a result of their proven efficacy, lower costs and positive patient uptake. However, the gastrointestinal barrier is still the main obstacle to surmount in chemother- apeutic oral delivery. Anticancer nanomedicines have been proposed to solve this quandary. Among these, lipid nanoparticles are described to be efficiently absorbed while protecting drugs from early degradation in hostile environments. Their intestinal lymphatic tropism or mucoadhesive/penetrative properties give them unique characteristics for oral administration. Considering that chronic cancer cases are increasing over time, it is important to be able to provide treatments with low toxicity and low prices. The challenges, opportunities and therapeutic perspectives of lipid nanoparticles in this area will be dis- cussed in this review, taking into consideration the pre-clinical and clinical progress made in the last decade.

Files in This Item:
Thumbnail
File
1-s2.0-S0169409X21000703-main.pdf
Description
Size
1.19 MB
Format
Adobe PDF


Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.